- Fecal Incontinence
The primary goal of the educational activities proposed in this document is to encourage the application of the latest advances in evidence-based medicine to achieve improved outcomes for patients with IBD.
This activity is designed for gastroenterology nurse practitioners, physician assistants and nurses from community-based practices.
Upon completion of this activity, participants should be able to:
Discuss the pathophysiology and current diagnostic strategies for IBD
Describe current management options for patients with IBD
Discuss the psychosocial impact of IBD and strategies for providing psychosocial support to patients and their families
Improve competence in caring for patients with IBD
Recognize barriers to optimal IBD treatment
Incorporate practical tools to manage access barriers and facilitate timely approval of therapies in IBD
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 18.25 contact hours may be earned for successful completion of this activity.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and GI Health Foundation. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207. This program is accredited for 18.25 contact hours. Program ID #5790.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 18.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity was planned in accordance with AAPA CME Criteria for Live Programs and for Commercial Support of Live Programs.
Disclosure of conflicts of interest
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc. All other staff at the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation have no relationships to disclose.
Americans with Disabilities Act
The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact us prior to the event at 877-782-4532.
This activity is supported by an educational grant from Janssen Biotech, Inc., Pfizer Inc. and Takeda Pharmaceuticals U.S.A., Inc.